Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility

References

• BanegasJRRodríguez-ArtalejoFde la Cruz TrocaJJBlood Pressure in Spain: distribution, awareness, control and benefits of a reduction in average pressureHypertension19983299810029856963
   PubMed Web of Science ®Google Scholar
• WangYRAlexanderGCStaffordRSOutpatient hypertension treatment, treatment intensification, and control in Western Europe and the United StatesArch Intern Med200716714114717242314
   PubMed Web of Science ®Google Scholar
• OngKLCheungBMManYBPrevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004Hypertension200749697517159087
   PubMed Web of Science ®Google Scholar
• BanegasJRRodriguez-ArtalejoFGracianiAMortality attributable to cardiovascular risk factors in SpainEur J Clin Nutr200357Suppl 1S18S2112947446
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakA2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens2007251105118717563527
   PubMed Web of Science ®Google Scholar
• BrittonKAGazianoJMDjousséLNormal systolic blood pressure and risk of heart failure in US male physiciansEur J Heart Fail2009111129113419861382
   PubMed Web of Science ®Google Scholar
• ManciaGMesserliFBakrisGBlood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril StudyHypertension20075029930517606861
   PubMed Web of Science ®Google Scholar
• CollinsRPetoRMacMahonSBlood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextLancet19903358278381969567
   PubMed Web of Science ®Google Scholar
• BarriosVBanegasJRRuilopeLMEvolution of blood pressure control in SpainJ Hypertens2007251975197717762665
   PubMed Web of Science ®Google Scholar
• KotsevaKWoodDDe BackerGEUROASPIRE Study GroupCardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countriesLancet200937392994019286092
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarCCalderonABlood pressure and lipid goal attainment in the hypertensive population in the primary care setting in SpainJ Clin Hypertens (Greenwich)2007932432917485967
   PubMedGoogle Scholar
• BarriosVEscobarCCalderonACONTROLRISK Investigators Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK studyJ Hum Hypertens20072147948517314997
   PubMed Web of Science ®Google Scholar
• Marquez-ContrerasECocaAde la FigueraMCardiovascular risk profile of uncontrolled hypertensive patients. The Control-Project studyMed Clin (Barc)2007128869117288921
   PubMed Web of Science ®Google Scholar
• RydenLStandlEBartnikMGuidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)Eur Heart J2007288813617220161
   PubMed Web of Science ®Google Scholar
• SicaDARationale for fixed-dose combinations in the treatment of hypertension: the cycle repeatsDrugs2002624462
   Web of Science ®Google Scholar
• MotwaniJGCombining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertensionJ Renin Angiotensin Aldosterone Syst20023727712228846
   PubMed Web of Science ®Google Scholar
• ManciaGLaurentSAgabiti-RoseiEReappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force documentJ Hypertens20091015 [Epub ahead of print]
   Web of Science ®Google Scholar
• AmarJVaurLPerretMPRATIK study investigators. Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study)J Hypertens20022077978411910316
   PubMed Web of Science ®Google Scholar
• CocaABlood pressure control among treated hypertensive patients by Primary Care in Spain. The 2003 Controlpres studyHipertension200522514
   Google Scholar
• BangaloreSKamalakkannanGParkarSFixed-dose combinations improve medication compliance: a meta-analysisAm J Med200712071371917679131
   PubMed Web of Science ®Google Scholar
• VolpeMAngiotensin II: an amplifier of cardiovascular riskCurr Hypertens Rep2004624724815257857
   PubMed Web of Science ®Google Scholar
• SchmiederREThe role of non-haemodynamic factors of the genesis of LVHNephrol Dial Transplant2005202610261216221701
   PubMed Web of Science ®Google Scholar
• LevyDGarrisonRJSavageDDPrognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart StudyN Engl J Med1990322156115662139921
   PubMed Web of Science ®Google Scholar
• KlingbeilAUSchneiderMMartusPA meta-analysis of the effects of treatment on left ventricular mass in essential hypertensionAm J Med2003115414612867233
   PubMed Web of Science ®Google Scholar
• EscobarCBarriosVCalderónAElectrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA StudyJ Clin Hypertens (Greenwich)20081020821418326961
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarCEcharriRNew therapeutic progress in the cardio-renal protection of the hypertensive patient with a focus on olmesartanHot Topics in Hypertension20098716
   Google Scholar
• YusufSSleightPPogueJfor the Hearth Outcomes Prevention Evaluation (HOPE) Study GroupEffects of angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patientsN Engl J Med200034214515310639539
   PubMed Web of Science ®Google Scholar
• WachtellKOlsenMHDahlofBMicroalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hyper tension (LIFE) studyJ Hypertension200220405412
   PubMed Web of Science ®Google Scholar
• SchachingerVBrittenMBZeiherAMPrognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart diseaseCirculation20001011899190610779454
   PubMed Web of Science ®Google Scholar
• TardiffJCAngiotensin-converting enzyme inhibitors and atherosclerotic plaque: a key role in the cardiovascular protection of patients with coronary artery diseaseEur Heart J Supple200911Suppl EE9E16
   Web of Science ®Google Scholar
• BonettiPOLermanLOLermanAEndothelial dysfunction: a marker of atherosclerotic riskArterioscler Thromb Vasc Biol20032316817512588755
   PubMed Web of Science ®Google Scholar
• BehrendtDGanzPEndothelial function. From vascular biology to clinical applicationsAm J Cardiol20029040L48L
   PubMed Web of Science ®Google Scholar
• BuusNHJorgensenCGMulvanyMJLarge and small artery endothelial function in patients with essential hypertension – effect of ACE inhibition and beta-blockadeBlood Press20071610611317612909
   PubMed Web of Science ®Google Scholar
• COVERSYL PLUS® Data sheetIn Information for health professionals http://www.medsafe.govt.nz/profs/datasheet/c/CoversylPlustab.htm. Last update 2006 March 03. Accessed January 2010.
   Google Scholar
• SongJCWhiteCMClinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an updateClin Pharmacokinet20024120722411929321
   PubMed Web of Science ®Google Scholar
• BrugtsJJFerrariRSimoonsMLAngiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular diseaseExpert Rev Cardiovasc Ther2009734536019379059
   PubMedGoogle Scholar
• RobinsonDMWellingtonKIndapamide sustained release: a review of its use in the treatment of hypertensionDrugs20066625727116451099
   PubMed Web of Science ®Google Scholar
• SchiaviPJochemsenRGuezDPharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteersFundam Clin Pharmacol20001413914610796061
   PubMed Web of Science ®Google Scholar
• MathesonAJCheerSMGoaKLPerindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertensionDrugs2001611211122911465878
   PubMed Web of Science ®Google Scholar
• SungSHWuTCLinSJChenJWEfficacy of a very-low-dose combination of perindopril and indapamide – preterax compared with cilazapril monotherapy in patients with inadequate blood pressure control – a randomized, double-blind, add-on studyJ Chin Med Assoc20087124725318490229
   PubMed Web of Science ®Google Scholar
• MouradJJWaeberBZannadFComparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approachJ Hypertens2004222379238615614033
   PubMed Web of Science ®Google Scholar
• WaeberBMouradJJApplication in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertensionVasc Health Risk Manag2008424925218629368
   PubMedGoogle Scholar
• MouradJJLameiraDGuillausseauPJBlood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 studyVasc Health Risk Manag2008444345118561520
   PubMedGoogle Scholar
• KangSWuYFAnNRenMA systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertensionClin Ther20042625727015038948
   PubMed Web of Science ®Google Scholar
• ConcatoJShahNHorwitzRIRandomized, controlled trials, observational studies, and the hierarchy of research designsN Engl J Med20003421887189210861325
   PubMed Web of Science ®Google Scholar
• StegPGLopez-SendonJLopez de SaEExternal validity of clinical trials in acute myocardial infarctionArch Intern Med2007167687317210880
   PubMedGoogle Scholar
• BarriosVEscobarCDivisonJAMedialdeaFClinical experience with a low-dose fixed combination of perindopril plus indapamide in a primary-care setting: the PRETEND studyTherapy20074677683
   Google Scholar
• BarriosVEscobarCDivisonJAMedialdeaFLow-dose fixed combination of perindopril plus indapamide in the diabetic hypertensive populationExpert Rev Cardiovasc Ther200861063106918793109
   PubMedGoogle Scholar
• DahlöfBGossePGuéretPPerindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL studyJ Hypertens2005232063207016208150
   PubMed Web of Science ®Google Scholar
• AsmarRGarcia-PuigJGossePAmbulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapyVasc Health Risk Manag2007337138017969366
   PubMedGoogle Scholar
• MogensenCEVibertiGHalimiSEffect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIERHypertension2003411063107112654706
   PubMed Web of Science ®Google Scholar
• BeulensJWPatelAVingerlingJREffects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trialDiabetologia2009522027203619633827
   PubMed Web of Science ®Google Scholar
• CampbellDJA review of Perindopril in the reduction of cardiovascular eventsVasc Health Risk Manag2006211712417319455
   PubMedGoogle Scholar
• PROGRESS Collaborative GroupRandomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attackLancet20013581033104111589932
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative GroupEffects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular diseaseEur Heart J20032447548412633548
   PubMed Web of Science ®Google Scholar
• HisatomiACraigATeruoOfor the PROGRESS Collaborative GroupPerindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trialJ Hypertens20102839540019864958
   PubMed Web of Science ®Google Scholar
• PatelAADVANCE Collaborative GroupMacMahonSEffects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialLancet200737082984017765963
   PubMed Web of Science ®Google Scholar
• ChalmersJJoshiRKengneAPADVANCE Collaborative GroupEfficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidenceJ Hypertens200826Suppl 3S23S30
   Google Scholar
• WaeberBde la SierraARuilopeLMThe ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitusAm J Cardiovasc Drugs2009928329119791837
   PubMed Web of Science ®Google Scholar
• ZoungasSde GalanBENinomiyaTCombined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trialDiabetes Care2009322068207419651921
   PubMed Web of Science ®Google Scholar
• DuXNinomiyaTde GalanBADVANCE Collaborative GroupRisks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE studyEur Heart J2009301128113519282274
   PubMed Web of Science ®Google Scholar
• BrugtsJJNinomiyaTBoersmaEThe consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trialsEur Heart J2009301385139419346520
   PubMed Web of Science ®Google Scholar
• BeckettNSPetersRFletcherAEHYVET Study GroupTreatment of hypertension in patients 80 years of age or olderN Engl J Med20083581887189818378519
   PubMed Web of Science ®Google Scholar
• JamersonKWeberMABakrisGLBenazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsN Engl J Med20083592417242819052124
   PubMed Web of Science ®Google Scholar